Erratum: Correction: Glycogen Synthase Kinase-3 Inhibition Sensitizes Pancreatic Cancer Cells to Chemotherapy by Abrogating the TopBP1/ATR-mediated DNA Damage Response (Clinical cancer research : an official journal of the American Association for Cancer Research (2019) 25 21 (6452-6462))

Li Ding; Vijay S. Madamsetty; Spencer Kiers; Olga Alekhina; Andrey Ugolkov; John Dube; Yu Zhang; Jin San Zhang; Enfeng Wang; Shamit K. Dutta; Daniel M. Schmitt; Francis J. Giles; Alan P. Kozikowski; Andrew P. Mazar; Debabrata Mukhopadhyay; Daniel D. Billadeau

doi:10.1158/1078-0432.CCR-21-2114

Erratum: Correction: Glycogen Synthase Kinase-3 Inhibition Sensitizes Pancreatic Cancer Cells to Chemotherapy by Abrogating the TopBP1/ATR-mediated DNA Damage Response (Clinical cancer research : an official journal of the American Association for Cancer Research (2019) 25 21 (6452-6462))

Li Ding, Vijay S. Madamsetty, Spencer Kiers, Olga Alekhina, Andrey Ugolkov, John Dube, Yu Zhang, Jin San Zhang, Enfeng Wang, Shamit K. Dutta, Daniel M. Schmitt, Francis J. Giles, Alan P. Kozikowski, Andrew P. Mazar, Debabrata Mukhopadhyay, Daniel D. Billadeau

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	4128
Number of pages	1
Journal	Clinical cancer research : an official journal of the American Association for Cancer Research
Volume	27
Issue number	14
DOIs	https://doi.org/10.1158/1078-0432.CCR-21-2114
State	Published - Jul 15 2021

ASJC Scopus subject areas

General Medicine

Access to Document

10.1158/1078-0432.CCR-21-2114

Cite this

Ding, L., Madamsetty, V. S., Kiers, S., Alekhina, O., Ugolkov, A., Dube, J., Zhang, Y., Zhang, J. S., Wang, E., Dutta, S. K., Schmitt, D. M., Giles, F. J., Kozikowski, A. P., Mazar, A. P., Mukhopadhyay, D., & Billadeau, D. D. (2021). Erratum: Correction: Glycogen Synthase Kinase-3 Inhibition Sensitizes Pancreatic Cancer Cells to Chemotherapy by Abrogating the TopBP1/ATR-mediated DNA Damage Response (Clinical cancer research : an official journal of the American Association for Cancer Research (2019) 25 21 (6452-6462)). Clinical cancer research : an official journal of the American Association for Cancer Research, 27(14), 4128. https://doi.org/10.1158/1078-0432.CCR-21-2114

Erratum: Correction: Glycogen Synthase Kinase-3 Inhibition Sensitizes Pancreatic Cancer Cells to Chemotherapy by Abrogating the TopBP1/ATR-mediated DNA Damage Response (Clinical cancer research : an official journal of the American Association for Cancer Research (2019) 25 21 (6452-6462)). / Ding, Li; Madamsetty, Vijay S.; Kiers, Spencer et al.
In: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 27, No. 14, 15.07.2021, p. 4128.

Research output: Contribution to journal › Comment/debate › peer-review

Ding, L, Madamsetty, VS, Kiers, S, Alekhina, O, Ugolkov, A, Dube, J, Zhang, Y, Zhang, JS, Wang, E, Dutta, SK, Schmitt, DM, Giles, FJ, Kozikowski, AP, Mazar, AP, Mukhopadhyay, D & Billadeau, DD 2021, 'Erratum: Correction: Glycogen Synthase Kinase-3 Inhibition Sensitizes Pancreatic Cancer Cells to Chemotherapy by Abrogating the TopBP1/ATR-mediated DNA Damage Response (Clinical cancer research : an official journal of the American Association for Cancer Research (2019) 25 21 (6452-6462))', Clinical cancer research : an official journal of the American Association for Cancer Research, vol. 27, no. 14, pp. 4128. https://doi.org/10.1158/1078-0432.CCR-21-2114

Ding L, Madamsetty VS, Kiers S, Alekhina O, Ugolkov A, Dube J et al. Erratum: Correction: Glycogen Synthase Kinase-3 Inhibition Sensitizes Pancreatic Cancer Cells to Chemotherapy by Abrogating the TopBP1/ATR-mediated DNA Damage Response (Clinical cancer research : an official journal of the American Association for Cancer Research (2019) 25 21 (6452-6462)). Clinical cancer research : an official journal of the American Association for Cancer Research. 2021 Jul 15;27(14):4128. doi: 10.1158/1078-0432.CCR-21-2114

Ding, Li ; Madamsetty, Vijay S. ; Kiers, Spencer et al. / Erratum : Correction: Glycogen Synthase Kinase-3 Inhibition Sensitizes Pancreatic Cancer Cells to Chemotherapy by Abrogating the TopBP1/ATR-mediated DNA Damage Response (Clinical cancer research : an official journal of the American Association for Cancer Research (2019) 25 21 (6452-6462)). In: Clinical cancer research : an official journal of the American Association for Cancer Research. 2021 ; Vol. 27, No. 14. pp. 4128.

@article{7f280d2cd3544ff18cc5af081b289832,

title = "Erratum: Correction: Glycogen Synthase Kinase-3 Inhibition Sensitizes Pancreatic Cancer Cells to Chemotherapy by Abrogating the TopBP1/ATR-mediated DNA Damage Response (Clinical cancer research : an official journal of the American Association for Cancer Research (2019) 25 21 (6452-6462))",

author = "Li Ding and Madamsetty, {Vijay S.} and Spencer Kiers and Olga Alekhina and Andrey Ugolkov and John Dube and Yu Zhang and Zhang, {Jin San} and Enfeng Wang and Dutta, {Shamit K.} and Schmitt, {Daniel M.} and Giles, {Francis J.} and Kozikowski, {Alan P.} and Mazar, {Andrew P.} and Debabrata Mukhopadhyay and Billadeau, {Daniel D.}",

year = "2021",

month = jul,

day = "15",

doi = "10.1158/1078-0432.CCR-21-2114",

language = "English (US)",

volume = "27",

pages = "4128",

journal = "Clinical cancer research : an official journal of the American Association for Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "14",

}

TY - JOUR

T1 - Erratum

T2 - Correction: Glycogen Synthase Kinase-3 Inhibition Sensitizes Pancreatic Cancer Cells to Chemotherapy by Abrogating the TopBP1/ATR-mediated DNA Damage Response (Clinical cancer research : an official journal of the American Association for Cancer Research (2019) 25 21 (6452-6462))

AU - Ding, Li

AU - Madamsetty, Vijay S.

AU - Kiers, Spencer

AU - Alekhina, Olga

AU - Ugolkov, Andrey

AU - Dube, John

AU - Zhang, Yu

AU - Zhang, Jin San

AU - Wang, Enfeng

AU - Dutta, Shamit K.

AU - Schmitt, Daniel M.

AU - Giles, Francis J.

AU - Kozikowski, Alan P.

AU - Mazar, Andrew P.

AU - Mukhopadhyay, Debabrata

AU - Billadeau, Daniel D.

PY - 2021/7/15

Y1 - 2021/7/15

UR - http://www.scopus.com/inward/record.url?scp=85111719413&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85111719413&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-21-2114

DO - 10.1158/1078-0432.CCR-21-2114

M3 - Comment/debate

C2 - 34261773

AN - SCOPUS:85111719413

SN - 1078-0432

VL - 27

SP - 4128

JO - Clinical cancer research : an official journal of the American Association for Cancer Research

JF - Clinical cancer research : an official journal of the American Association for Cancer Research

IS - 14

ER -

Erratum: Correction: Glycogen Synthase Kinase-3 Inhibition Sensitizes Pancreatic Cancer Cells to Chemotherapy by Abrogating the TopBP1/ATR-mediated DNA Damage Response (Clinical cancer research : an official journal of the American Association for Cancer Research (2019) 25 21 (6452-6462))

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this